References
- Ferlay JSI, Ervik M, Dikshit R, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC cancer base no. 11. Lyon: IARC; 2013.
- Howlader NNA, Krapcho M, Garshell J, et al. SEER cancer statistics review, 1975–2012. Bethesda (MD): National Cancer Institute; 2012.
- Hurria A, Levit LA, Dale W, et al. Improving the evidence base for treating older adults with cancer: American Society of Clinical Oncology Statement. J Clin Oncol. 2015;33:3826–3833.
- Wildiers H, Mauer M, Pallis A, et al. End points and trial design in geriatric oncology research: a joint European Organisation for Research and Treatment of Cancer–Alliance for Clinical Trials in Oncology–International Society of Geriatric Oncology position article. J Clin Oncol. 2013;31:3711–3718.
- Hurria A, Cirrincione CT, Muss HB, et al. Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401. J Clin Oncol. 2011;29:1290–1296.
- Hamaker ME, Wildes TM, Rostoft T. Time to stop saying geriatric assessment is too time consuming. J Clin Oncol. 2017 Jun 19:JCO2017728170. [Epub ahead of print]. DOI:10.1200/JCO.2017.72.8170
- Hurria A, Mohile S, Gajra A, et al. Validation of a prediction tool for chemotherapy toxicity in older adults with cancer. J Clin Oncol. 2016;34:2366–2371.
- Extermann M, Boler I, Reich RR, et al. Predicting the risk of chemotherapy toxicity in older patients: the Chemotherapy Risk Assessment Scale For High-Age Patients (CRASH) score. Cancer. 2012;118:3377–3386.
- Muss HB, Berry DA, Cirrincione CT, et al. Adjuvant chemotherapy in older women with early-stage breast cancer. N Engl J Med. 2009;360:2055–2065.
- Kornblith AB, Lan L, Archer L, et al. Quality of life of older patients with early-stage breast cancer receiving adjuvant chemotherapy: a companion study to Cancer and Leukemia Group B 49907. J Clin Oncol. 2011;29:1022–1028.
- Freedman RA, Pitcher B, Keating NL, et al. Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907. Breast Cancer Res Treat. 2013;139:607–616.
- Kim ES, Bernstein D, Hilsenbeck SG, et al. Modernizing eligibility criteria for molecularly driven trials. J Clin Oncol. 2015;33:2815–2820.
- Lichtman SM, Cirrincione CT, Hurria A, et al. Effect of pretreatment renal function on treatment and clinical outcomes in the adjuvant treatment of older women with breast cancer: alliance A171201, an ancillary study of CALGB/CTSU 49907. J Clin Oncol. 2016;34:699–705.
- Corre R, Greillier L, Le Caer H, et al. Use of a comprehensive geriatric assessment for the management of elderly patients with advanced non-small-cell lung cancer: the phase III randomized ESOGIA-GFPC-GECP 08–02 study. J Clin Oncol. 2016;34:1476–1483.
- Brain EGC, Mertens C, Girre V, et al. Impact of liposomal doxorubicin-based adjuvant chemotherapy on autonomy in women over 70 with hormone-receptor-negative breast carcinoma: A French Geriatric Oncology Group (GERICO) phase III multicentre trial. Crit Rev Oncol Hematol. 2011;80:160–170.
- Seymour MT, Thompson LC, Wasan HS, et al. Chemotherapy options in elderly and frail patients with metastatic colorectal cancer (MRC FOCUS2): an open-label, randomised factorial trial. Lancet. 2011;377:1749–1759.
- Nipp RD, Yao NA, Lowenstein LM, et al. Pragmatic study designs for older adults with cancer: report from the U13 Conference. J Geriatr Oncol. 2016;7:234–241.
- von Gruenigen VE, Huang HQ, Beumer JH, et al. Chemotherapy completion in elderly women with ovarian, primary peritoneal or fallopian tube cancer - An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2017;144:459–467.
- Townsley CA, Selby R, Siu LL. Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials. J Clin Oncol. 2005;23:3112–3124.